Business Via targets 25%+ revenue growth and first profitable quarter in Q4 2026 amid AI-driven product expansion
Business Fulgent Genetics forecasts $350M 2026 revenue and 53% AP growth as Bako, StrataDx acquisitions reshape customer mix
Business ALX Oncology outlines pivotal trial readiness by end of 2026 with expanded ASPEN-09 study and $150M financing
Business RLJ Lodging Trust targets 0.5%–3% RevPAR growth for 2026 amid urban market momentum and capital allocation flexibility
Business Hawaiian Electric signals $550M–$700M capex for 2026 as wildfire settlements near final approval